作者: Mark F. Pittenger , Alastair Morgan Mackay , Bradley J. Martin , Stephen L. Gordon
DOI:
关键词:
摘要: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual cardiomyocyte amount mesenchymal stem cells. These cells can be administered as liquid injectible or preparation matrix which becomes solid semi-solid. The genetically modified enhance myocardial differentiation and integration. Also disclosed replacing ex valve implantation.